General Information of the Compound
Compound ID
CP0148605
Compound Name
2-[4-(6-benzyl-2-pyridin-3-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl)piperazin-1-yl]acetamide
    Show/Hide
Structure
Formula
C25H29N7O
Molecular Weight
443.555
Canonical SMILES
NC(=O)CN1CCN(CC1)c1nc(nc2CCN(Cc3ccccc3)Cc12)-c1cccnc1
    Show/Hide
InChI
InChI=1S/C25H29N7O/c26-23(33)18-30-11-13-32(14-12-30)25-21-17-31(16-19-5-2-1-3-6-19)10-8-22(21)28-24(29-25)20-7-4-9-27-15-20/h1-7,9,15H,8,10-14,16-18H2,(H2,26,33)
    Show/Hide
InChIKey
MEHKDCINYAQEKC-UHFFFAOYSA-N
Physicochemical Property
logP
1.7042
Rotatable Bonds
6
Heavy Atom Count
33
Polar Areas
91.48
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
33

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 127040944
ChEMBL ID
CHEMBL3745748
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000535 CFBE41o- Homo sapiens (Human)  1
1
EC50 = 100000 nM
   TI
   LI
   LO
   TS